Conversion Study From Cyclosporine to FK506MR Based Immunosuppression in Kidney Transplant Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

346

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Transplantation
Interventions
DRUG

tacrolimus

immunosuppression

Trial Locations (56)

Unknown

Innsbruck

Linz

Vienna

Brussels

Edegem

Leuven

Liège

Roeselare

Olomouc

Prague

Aarhus

Helsinki

Bordeaux

Brest

Paris

Pierre-Bénite

Strasbourg

Toulouse

Tours

Vandœuvre-lès-Nancy

Berlin

Cologne

Essen

Halle

Hanover

Heidelberg

Leipzig

Lübeck

Munich

Tübingen

Budapest

Debrecen

Bologna

Cagliari

Florence

Genova

L’Aquila

Milan

Modena

Napoli

Padua

Treviso

Udine

Gdansk

Lublin

Poznan

Warsaw

Alicante

Badajoz

Barakaldo

Madrid

Oviedo

Palma de Mallorca

Salamanca

Lund

Zurich

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY